Cell-derived membrane biomimetic nanocarriers for targeted therapy of pulmonary disease

Pulmonary diseases are currently one of the major threats of human health, especially considering the recent COVID-19 pandemic. However, the current treatments are facing the challenges like insufficient local drug concentrations, the fast lung clearance and risks to induce unexpected inflammation....

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xixi, Zhang, Tianyuan, Huang, Ting, Zhou, Yanjun, Gao, Jianqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014644/
https://www.ncbi.nlm.nih.gov/pubmed/35447225
http://dx.doi.org/10.1016/j.ijpharm.2022.121757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014644/
https://www.ncbi.nlm.nih.gov/pubmed/35447225
http://dx.doi.org/10.1016/j.ijpharm.2022.121757

Ejemplares similares